Sanofi to buy Bioverativ for $11.6bn
oonal / iStockphoto.com
Switzerland-based Roche has revealed plans to acquire a healthcare technology company for $1.9 billion.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Roche, Flatiron Health, cancer, oncology, mergers & acquisitions, biotechnology, data, research, electronic health records